Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers

Схожие документы

• Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
  по: Raya-Cruz, Manuel, et al.
  Опубликовано: (2015)
• Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study
  по: Reinés, Juan Buades, et al.
  Опубликовано: (2014)
• Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy
  по: Schmidt, Hartmut H.‐J., et al.
  Опубликовано: (2016)
• Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers
  по: Migueres, Marion, et al.
  Опубликовано: (2020)
• Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers
  по: Chen, Qin, et al.
  Опубликовано: (2019)